Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?

被引:2
|
作者
Drueeke, Tilman B. [1 ,2 ]
Floege, Juergen [3 ]
机构
[1] Paris Sud Univ, Inserm U 1018, Ctr Rech Epidemiol & Sante Populat CESP, Paris lle de France Ouest Univ, Villejuif, France
[2] Paris Saclay Univ, Villejuif, France
[3] Rheinisch Westfalische Tech Hsch Aachen, Univ Hosp, Dept Nephrol & Clin Immunol, Aachen, Germany
关键词
PTH;
D O I
10.1016/j.kint.2021.01.019
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In chronic kidney disease, parathyroid hormone (PTH), like all proteins, can undergo post-translational modifications, including oxidation. This can lead to structural and functional changes of the hormone. It has been hypothesized that currently used PTH measurement methods do not adequately reflect PTH-related bone and cardiovascular abnormalities in chronic kidney disease owing to the presence of oxidized, biologically inactive PTH in the circulation. Ursem et al. now report a strong correlation between serum non-oxidized and total PTH, and comparable associations with histomorphometric and circulating bone turnover markers, pleading against this hypothesis.
引用
收藏
页码:1070 / 1072
页数:3
相关论文
共 50 条
  • [31] Parathyroid hormone, kidney disease, evidence and guidelines
    Lamb, Edmund J.
    Vickery, Susan
    Ellis, Andy R.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 1 - 4
  • [32] Parathyroid Hormone Concentration in Dogs Affected by Acute Kidney Injury Compared with Healthy and Chronic Kidney Disease
    Zambarbieri, Jari
    Monari, Erika
    Dondi, Francesco
    Moretti, Pierangelo
    Giordano, Alessia
    Scarpa, Paola
    VETERINARY SCIENCES, 2025, 12 (02)
  • [33] Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease
    Evenepoel, Pieter
    Jorgensen, Hanne Skou
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (04): : 383 - 390
  • [34] Experiences with measuring parathyroid hormone 1-34 in patients with chronic kidney disease
    Hauge, Sabina Chaudhary
    Jorgensen, Niklas Rye
    Hansen, Ditte
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (03): : 204 - 206
  • [35] Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease
    Choi, Chang Kyun
    Kweon, Sun-Seog
    Lee, Young-Hoon
    Nam, Hae-Sung
    Park, Kyeong-Soo
    Ryu, So-Yeon
    Choi, Seong-Woo
    Kim, Sun A.
    Shin, Min-Ho
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (05) : 825 - 834
  • [36] Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease
    Nakagawa, Yosuke
    Komaba, Hirotaka
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (03) : 407 - 415
  • [37] Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease
    Chang Kyun Choi
    Sun-Seog Kweon
    Young-Hoon Lee
    Hae-Sung Nam
    Kyeong-Soo Park
    So-Yeon Ryu
    Seong-Woo Choi
    Sun A. Kim
    Min-Ho Shin
    Journal of Bone and Mineral Metabolism, 2019, 37 : 825 - 834
  • [38] Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
    Anton Lishmanov
    Smrita Dorairajan
    Youngju Pak
    Kunal Chaudhary
    Anand Chockalingam
    International Urology and Nephrology, 2012, 44 : 541 - 547
  • [39] Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease
    Chrysoula Pipili
    Chrysostomos Dimitriadis
    Nigar Sekercioglu
    Joanne M. Bargman
    Dimitrios D. Oreopoulos
    International Urology and Nephrology, 2012, 44 : 167 - 171
  • [40] Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
    Lishmanov, Anton
    Dorairajan, Smrita
    Pak, Youngju
    Chaudhary, Kunal
    Chockalingam, Anand
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 541 - 547